Replies to post #11891 on Applied DNA Sciences Inc (APDN)

[Apdn believer]

You do make some valid points AG. I did wonder why the deal with crede at .186

My rational was simply they needed the money sooner rather than later. I don't think many of us expect q4 to be profitable. The good dr cannot earn his pay unless they are profitable as I understand it so they must be close. Q1 is much more likely to achieve a profit.

I do think the PPS will move on good sales. Sales are the lifeblood of any business and all other numbers fall in line eventually, but only if sales are strong. You are right of course costs will have gone up but as long as sales grow strongly the nett loss will reduce anyway and then we enter profits :)

As you say the financials will be interesting I just hope the market appreciate the achievements this year. Turnover year on year has grown dramatically and as I said if you have sales the rest will fall into place.

[Golden Cross]

Do you expect it to be more than 170K$ in rev?

[Apdn believer]

Just been looking at the numbers AG both published in Q3 and expected in Q4. Since the announcement of the mandate turnover in Q3 rose by 127% to a then quarter record. Expected figures for Q4 will be around 400% better than the same period a year earlier another quarter record. Sales for this fiscal year should come in at around $3Mill.

I believe that many investors or "experts" look for trends in a business. APDN currently has a red hot sales trend. I understand i am looking at quarters not years but because of the mandate and the increased attention globally i think its fair to say that these quarters Q3 and Q4 are more realistic than perhaps Q1 in the prior fiscal year. If you apply these percentages to the next fiscal year expected turnover could be speculated at $7 Mill to $15 Mill. Although i said earlier i expect $10M next year i have not factored in any additional work obtained and whats interesting is the good Dr himself said that this business will effectively snowball once the ball starts rolling.

Of course if you apply the same growth factor achived from 2010 to 2011 and apply it to this coming year turnover could be speculated at $37,680,000. Unlikely next year perhaps but 2014 ??

There is a real trend here that i think has the attention of some of the market. Will the pps react well to the numbers ? who knows. One thing i do hope is that as APDN officially report the fact that the need for their product is growing dramatically improving income streams and bottom line the market acknowledges that fact and given the global potential of this market buy into potentially one of the biggest success stories in recent times.

[Apdn believer]

Just been looking at the numbers AG both published in Q3 and expected in Q4. Since the announcement of the mandate turnover in Q3 rose by 127% to a then quarter record. Expected figures for Q4 will be around 400% better than the same period a year earlier another quarter record. Sales for this fiscal year should come in at around $3Mill.

I believe that many investors or "experts" look for trends in a business. APDN currently has a red hot sales trend. I understand i am looking at quarters not years but because of the mandate and the increased attention globally i think its fair to say that these quarters Q3 and Q4 are more realistic than perhaps Q1 in the prior fiscal year. If you apply these percentages to the next fiscal year expected turnover could be speculated at $7 Mill to $15 Mill. Although i said earlier i expect $10M next year i have not factored in any additional work obtained and whats interesting is the good Dr himself said that this business will effectively snowball once the ball starts rolling.

Of course if you apply the same growth factor achived from 2010 to 2011 and apply it to this coming year turnover could be speculated at $37,680,000. Unlikely next year perhaps but 2014 ??

There is a real trend here that i think has the attention of some of the market. Will the pps react well to the numbers ? who knows. One thing i do hope is that as APDN officially report the fact that the need for their product is growing dramatically improving income streams and bottom line the market acknowledges that fact and given the global potential of this market buy into potentially one of the biggest success stories in recent times.